AstraZeneca is paying $2.4bn for Fusion Pharmaceuticals - but actually is it getting
AstraZeneca PLC (LSE:AZN) is acquiring Canadas Fusion Pharmaceuticals for $2.4 billion, in a bid to effectively keep up with Joneses…
69,250€
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
The deal is AstraZenecas second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to…
AstraZeneca will buy Fusion Pharmaceuticals for ~$2B
…
AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer…
AstraZeneca to buy Fusion Pharma for $2 billion in cash By Reuters
AstraZeneca to buy Fusion Pharma for $2 billion in cash…